Glycopyrrolate Injection
Product Images NDC 55154-7475

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 55154-7475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

88945f94 Fad0 454b B72d 8ec2a8ab7cd8 00

NDC 55154-7475-5 is a prescription medicine available in a pack of 5 single-dose vials of Glycopyrrolate Injection USP, with each vial containing 0.2 mg/mL. It is not recommended for newborns and contains benzyl alcohol. The medicine is for intramuscular or intravenous administration and should be stored at room temperature between 20°C to 25°C. The dosage information can be found in the product insert. This unit dose package is only for institutional use and not child-resistant. Hikma Farmaceutica in Portugal produces it, and it is distributed by West-Ward and Cardinal Health in the USA.*

FDA Label Image

Glycopyrrolate Injection 1

This appears to be a chemical formula for a compound with the molecular weight of 398.33 g/mol. However, with just this limited information, it is not possible to identify the compound or provide any further useful description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.